Table 2.
Haematology parameters of the BALB/c mice on day 14 of application of additives
| Group | NC1 | NC2 | IC | LAB | Ref BALB/c |
|---|---|---|---|---|---|
| WBC (G/L) | 5.45 ± 0.42 | 6.19 ± 0.40 |
2.73 ± 0.47 **NC1, ***NC2 |
4.00 ± 0.41 **NC2 |
5.69–9.87 |
| Ly (G/L) | 4.04 ± 0.33 | 4.47 ± 0.29 |
1.29 ± 0.33 ***NC1, NC2 |
2.32 ± 0.29 **NC1, ***NC2 |
3.60–7.29 |
| Mo (G/L) | 0.17 ± 0.02 | 0.19 ± 0.02 | 0.11 ± 0.02 | 0.14 ± 0.02 | 0.34–0.70 |
| Gran (G/L) | 1.24 ± 0.13 | 1.53 ± 0.13 | 1.57 ± 0.25 | 1.54 ± 0.16 | 0.74–1.78 |
| Ly % | 73.89 ± 1.51 | 72.05 ± 1.13 |
42.01 ± 5.24 ***NC1, NC2 |
56.62 ± 2.10 | 55.06–73.44 |
| Mo % | 3.17 ± 0.32 | 3.38 ± 0.23 | 3.83 ± 0.14 |
4.24 ± 0.27 *NC1 |
3.75–7.26 |
| Gran % | 22.94 ± 1.23 | 24.58 ± 0.93 |
54.16 ± 5.16 ***NC1, NC2, LAB |
39.14 ± 2.01 ***NC1, NC2, |
10.46–18.94 |
| RBC (T/L) | 10.75 ± 0.52 | 9.73 ± 0.34 |
8.59 ± 0.75 *NC1 |
7.91 ± 0.43 ***NC1, *NC2 |
8.16–9.98 |
| HGB (g/L) | 185.8 ± 10.03 | 163.5 ± 5.61 |
140.2 ± 10.79 **NC1 |
131.3 ± 7.27 ***NC1, *NC2 |
124–154 |
| HCT % | 60.19 ± 3.03 | 54.11 ± 1.97 |
46.83 ± 4.15 *NC1 |
43.58 ± 2.36 ***NC1, *NC2 |
43.5–55.4 |
| MCV (fL) | 55.95 ± 0.33 | 55.61 ± 0.19 |
54.51 ± 0.21 **NC1, NC2 |
55.08 ± 0.21 | 50.8–55.6 |
| MCH (pg) | 17.17 ± 0.25 | 16.79 ± 0.20 | 16.51 ± 0.53 | 16.55 ± 0.19 | 13–15.5 |
| MCHC (g/L) | 307.3 ± 3.95 | 302.7 ± 3.68 | 304.0 ± 9.52 | 301.1 ± 3.32 | 239–280 |
| PLT (G/L) | 391.2 ± 88.43 | 512.0 ± 52.54 |
154.6 ± 39.88 **NC2 |
265.8 ± 50.09 *NC2 |
476–963 |
Control NC1 (n = 16), control NC2 (alginite, n = 16), IC (alginite + Salm. Typhimurium CCM 7205NAL, n = 17), LAB (alginite + Lact. reuteri CCM 8617 + Salm. Typhimurium CCM 7205NAL, n = 17), WBC white blood cells, Ly lymphocytes, Mo monocytes, Gran granulocytes, RBC red blood cells, HGB haemoglobin, HCT haematocrit, MCV mean corpuscular volume, MCH mean corpuscular haemoglobin, MCHC mean corpuscular haemoglobin concentration, PLT thrombocytes, Ref reference range [10]. The results are experience as the mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001